Buscar
Mostrando ítems 71-80 de 205
Effect of interferon-alpha on experimental septal fibrosis of the liver - study with a new model
(2001)
Interferon-alpha is used in antiviral therapy in humans, mainly for viral hepatitis B and C. An anti-fibrotic effect of interferon has been postulated even in the absence of anti-viral response, which suggests that interferon ...
Improved effects of viral gene delivery of human uPA plus biliodigestive anastomosis induce recovery from experimental biliary cirrhosis
(2004)
Gene therapy may represent a new avenue for the development of multimodal treatment for diverse forms of cirrhosis. This study explores the potential benefits of combining adenovirus-mediated human urokinase-plasminogen ...
Improved effects of viral gene delivery of human uPA plus biliodigestive anastomosis induce recovery from experimental biliary cirrhosis
(2004)
Gene therapy may represent a new avenue for the development of multimodal treatment for diverse forms of cirrhosis. This study explores the potential benefits of combining adenovirus-mediated human urokinase-plasminogen ...
Teste respiratório com isótopos estáveis do carbono para avaliação da função hepática nas fases da cirrose causada pela hepatite viral C
(Universidade Estadual Paulista (Unesp), 2017-02-21)
Atualmente cerca de 3% da população mundial está infectado pelo vírus da hepatite C (VHC), onde sua maior consequência é a cirrose hepática. Para o diagnóstico da cirrose hepática utiliza-se a biopsia hepática percutânea, ...
Effect of Interferon-a on Experimental Septal Fibrosis of the Liver - Study with a New Model
(Brasil, 2001)
Interferon-a is used in antiviral therapy in humans, mainly for viral hepatitis B and C. An anti-fibrotic effect of interferon has been postulated even in the absence of anti-viral response, which suggests that interferon ...
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease
(2016)
Background & AimsMacrophage activation plays a key pathogenic role in experimental non-alcoholic fatty liver disease (NAFLD) and contributes to the progression of steatohepatitis (NASH) and fibrosis. We studied macrophage ...
Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C
(MEXICAN ASSOC HEPATOLOGY, 2009)
Chronic hepatitis C (CHC) is one of the most important causes of chronic liver disease in the world, potentially resulting in cirrhosis, hepatocellular carcinoma, and the need for liver transplantation. Liver biopsy is ...